Co-Authors
This is a "connection" page, showing publications co-authored by Joaquim Mullol and Isam Alobid.
Connection Strength
4.090
-
ACE2 downregulation in olfactory mucosa: Eosinophilic rhinosinusitis as COVID-19 protective factor? Allergy. 2021 09; 76(9):2904-2907.
Score: 0.237
-
Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study). Curr Allergy Asthma Rep. 2020 11 08; 20(12):78.
Score: 0.228
-
Olfactory dysfunction during COVID-19 pandemic. Med Clin (Engl Ed). 2020 Nov 13; 155(9):403-408.
Score: 0.227
-
Chemosensory dysfunction in COVID-19 out-patients. Eur Arch Otorhinolaryngol. 2021 Mar; 278(3):695-702.
Score: 0.225
-
The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries. Curr Allergy Asthma Rep. 2020 08 03; 20(10):61.
Score: 0.224
-
Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients? Int Forum Allergy Rhinol. 2020 08; 10(8):951-952.
Score: 0.222
-
Smell and Taste Dysfunction in COVID-19 Is Associated With Younger Age in Ambulatory Settings: A Multicenter Cross-Sectional Study. J Investig Allergol Clin Immunol. 2020; 30(5):346-357.
Score: 0.222
-
[Olfactory dysfunction during COVID-19 pandemic]. Med Clin (Barc). 2020 11 13; 155(9):403-408.
Score: 0.222
-
Olfactory Dysfunction in the COVID-19 Outbreak. J Investig Allergol Clin Immunol. 2020; 30(5):317-326.
Score: 0.220
-
Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons. Mol Neurobiol. 2019 Dec; 56(12):8063-8075.
Score: 0.207
-
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers. Allergy Asthma Clin Immunol. 2018; 14:86.
Score: 0.200
-
Olfactory Training in Post-Traumatic Smell Impairment: Mild Improvement in Threshold Performances: Results from a Randomized Controlled Trial. J Neurotrauma. 2018 11 15; 35(22):2641-2652.
Score: 0.194
-
Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1752-1755.e3.
Score: 0.188
-
Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 2018 01 31; 8(1):e018788.
Score: 0.188
-
Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps. Laryngoscope. 2018 08; 128(8):1743-1751.
Score: 0.185
-
Olfactory function in an excitotoxic model for secondary neuronal degeneration: Role of dopaminergic interneurons. Neuroscience. 2017 Nov 19; 364:28-44.
Score: 0.183
-
Nasal obstructive disorders impair health-related quality of life in adolescents with persistent allergic rhinitis: A real-life study. Pediatr Allergy Immunol. 2017 08; 28(5):438-445.
Score: 0.180
-
High Frequency of Smell and Taste Dysfunction in Health Care Professionals With COVID-19 Working in Allergy Departments. J Investig Allergol Clin Immunol. 2021 Apr; 31(2):151-161.
Score: 0.059
-
Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China. Curr Med Sci. 2021 Feb; 41(1):14-23.
Score: 0.058
-
High frequency of smell and taste dysfunctions in allergy health care professionals suffering from COVID-19. J Investig Allergol Clin Immunol. 2021 01 19; 0.
Score: 0.058
-
Errors and Biases in Meta-analysis of the Prevalence of Olfactory Dysfunction in Patients With COVID-19. Otolaryngol Head Neck Surg. 2021 02; 164(2):455-456.
Score: 0.056
-
Functional Examination of the Upper and Lower Airways in Asthma and Respiratory Allergic Diseases: Considerations in the Post-SARS-CoV-2 Era. J Investig Allergol Clin Immunol. 2021 Feb 17; 31(1):17-35.
Score: 0.055
-
Patient Advisory Board for Chronic Rhinosinusitis - A EUFOREA initiative. Rhinology. 2019 Oct 01; 57(5):331-335.
Score: 0.053
-
The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology. 2019 Oct 01; 57(5):343-351.
Score: 0.053
-
EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis. Rhinology. 2019 06 01; 57(3):162-168.
Score: 0.052
-
Position paper on nasal obstruction: evaluation and treatment. J Investig Allergol Clin Immunol. 2018; 28(2):67-90.
Score: 0.047
-
Allergy rhinitis: similarities and differences between children and adults. Rhinology. 2017 Dec 01; 55(4):326-331.
Score: 0.047